Amgen
Search results
2 days ago · Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening...
Jun 28, 2024 · See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions.
4 days ago · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
3 days ago · The biopharmaceutical company earned $6.69 billion during the quarter, compared to the consensus estimate of $6.36 billion. Gilead Sciences had a trailing twelve-month return on equity of 24.34% and a net margin of 1.76%. Gilead Sciences's quarterly revenue was up 5.3% on a year-over-year basis.
3 days ago · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
4 days ago · Mirador Capital Partners LP boosted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.7% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,997 shares of the biopharmaceutical company’s stock after purchasing an additional 853 shares during the period. Mirador Capital Partners […]
Jun 28, 2024 · Latest Gilead Sciences Inc (GILD:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
